Signaling of transforming growth factor‐β family members through Smad proteins
暂无分享,去创建一个
Fumiko Itoh | Marie-José Goumans | M. Goumans | P. Dijke | Peter ten Dijke | S. Itoh | F. Itoh | Susumu Itoh
[1] J. Massagué,et al. Carboxy-terminally truncated Gli3 proteins associate with Smads , 1998, Nature Genetics.
[2] J. Massagué,et al. Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes. , 1997, Genes & development.
[3] A. Schier,et al. Nodal signalling in vertebrate development , 2000, Nature.
[4] R. Derynck,et al. Transcriptional Regulation of the Transforming Growth Factor-β-inducible Mouse Germ Line Ig α Constant Region Gene by Functional Cooperation of Smad, CREB, and AML Family Members* , 2000, The Journal of Biological Chemistry.
[5] Xing Shen,et al. TGF-beta-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein. , 1998, Molecular biology of the cell.
[6] Jian-ming Li,et al. Smad3-Smad4 and AP-1 Complexes Synergize in Transcriptional Activation of the c-Jun Promoter by Transforming Growth Factor β , 1999, Molecular and Cellular Biology.
[7] J. Wrana. Regulation of Smad Activity , 2000, Cell.
[8] K. Irie,et al. The oncoprotein Evi-1 represses TGF-β signalling by inhibiting Smad3 , 1998, Nature.
[9] H. Lodish,et al. Importin β Mediates Nuclear Translocation of Smad 3* , 2000, The Journal of Biological Chemistry.
[10] K. Miyazono,et al. Smad6 inhibits signalling by the TGF-β superfamily , 1997, Nature.
[11] Xin Chen,et al. A transcriptional partner for MAD proteins in TGF-β signalling , 1996, Nature.
[12] J. Graff,et al. Spemann organizer activity of Smad10. , 1999, Development.
[13] T. Grundström,et al. Smad and AML Proteins Synergistically Confer Transforming Growth Factor β1 Responsiveness to Human Germ-line IgA Genes* , 2000, The Journal of Biological Chemistry.
[14] J. Campisi,et al. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[15] S. Valgeirsdóttir,et al. Xenopus Smad4beta is the co-Smad component of developmentally regulated transcription factor complexes responsible for induction of early mesodermal genes. , 1999, Developmental biology.
[16] C. Heldin,et al. The L45 loop in type I receptors for TGF‐β family members is a critical determinant in specifying Smad isoform activation , 1998, FEBS letters.
[17] J. Massagué,et al. OAZ Uses Distinct DNA- and Protein-Binding Zinc Fingers in Separate BMP-Smad and Olf Signaling Pathways , 2000, Cell.
[18] R. Weinberg,et al. Interaction of the Ski Oncoprotein with Smad3 Regulates TGF-β Signaling , 1999 .
[19] J. Massagué,et al. Physical and Functional Interaction of SMADs and p300/CBP* , 1998, The Journal of Biological Chemistry.
[20] J. Massagué,et al. Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors , 1993, Cell.
[21] Anita B. Roberts,et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response , 1999, Nature Cell Biology.
[22] M. Sporn,et al. The Transforming Growth Factor-βs , 1991 .
[23] W. Wang,et al. Cooperative Binding of Smad Proteins to Two Adjacent DNA Elements in the Plasminogen Activator Inhibitor-1 Promoter Mediates Transforming Growth Factor β-induced Smad-dependent Transcriptional Activation* , 1999, The Journal of Biological Chemistry.
[24] Harold L. Moses,et al. STRAP and Smad7 Synergize in the Inhibition of Transforming Growth Factor β Signaling , 2000, Molecular and Cellular Biology.
[25] A. Roberts,et al. Smad-dependent Transcriptional Activation of Human Type VII Collagen Gene (COL7A1) Promoter by Transforming Growth Factor-β* , 1998, The Journal of Biological Chemistry.
[26] P. Hoodless,et al. MADR2 Is a Substrate of the TGFβ Receptor and Its Phosphorylation Is Required for Nuclear Accumulation and Signaling , 1996, Cell.
[27] J. L. Rosa,et al. Interaction and functional cooperation of NF-kappa B with Smads. Transcriptional regulation of the junB promoter. , 2000, The Journal of biological chemistry.
[28] J. Biggs,et al. The Role of the Smad3 Protein in Phorbol Ester-induced Promoter Expression* , 1999, The Journal of Biological Chemistry.
[29] Ester Piek,et al. Role of Transforming Growth Factor-β Signaling in Cancer , 2000 .
[30] Yigong Shi,et al. Crystal Structure of a Smad MH1 Domain Bound to DNA Insights on DNA Binding in TGF-β Signaling , 1998, Cell.
[31] V. Beneš,et al. Genomic locus and promoter region of rat Smad7, an important antagonist of TGFβ signaling , 2000, Mammalian Genome.
[32] Hong-Jian Zhu,et al. Smad7 Differentially Regulates Transforming Growth Factor β-mediated Signaling Pathways* , 1999, The Journal of Biological Chemistry.
[33] H. Lodish,et al. Specificity in transforming growth factor beta-induced transcription of the plasminogen activator inhibitor-1 gene: interactions of promoter DNA, transcription factor muE3, and Smad proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[34] E. Nishida,et al. Involvement of the p38 Mitogen-activated Protein Kinase Pathway in Transforming Growth Factor-β-induced Gene Expression* , 1999, The Journal of Biological Chemistry.
[35] H. Lodish,et al. A distinct nuclear localization signal in the N terminus of Smad 3 determines its ligand-induced nuclear translocation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[36] Kirby D. Johnson,et al. Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic , 1997, Nature.
[37] C. Heldin,et al. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members. , 1998, Biochemical and biophysical research communications.
[38] Takeshi Imamura,et al. Smad proteins exist as monomers in vivo and undergo homo‐ and hetero‐oligomerization upon activation by serine/threonine kinase receptors , 1998, The EMBO journal.
[39] Liliana Attisano,et al. SARA, a FYVE Domain Protein that Recruits Smad2 to the TGFβ Receptor , 1998, Cell.
[40] J. Massagué,et al. The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. , 1997, Genes & development.
[41] J. Massagué,et al. Smad1 Recognition and Activation by the ALK1 Group of Transforming Growth Factor-β Family Receptors* , 1999, The Journal of Biological Chemistry.
[42] C. Zimmerman,et al. Smad Proteins Physically Interact with Calmodulin* , 1998, The Journal of Biological Chemistry.
[43] L. Attisano,et al. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[44] R. Derynck,et al. Roles of Autocrine TGF-β Receptor and Smad Signaling in Adipocyte Differentiation , 2000, The Journal of cell biology.
[45] R. Frey,et al. Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFβ , 1999, Oncogene.
[46] J. Graff,et al. Smad3 Mutant Mice Develop Metastatic Colorectal Cancer , 1998, Cell.
[47] E. Li,et al. Smad2 role in mesoderm formation, left–right patterning and craniofacial development , 1998, Nature.
[48] K. Yamato,et al. Smad7 Is an Activin-inducible Inhibitor of Activin-induced Growth Arrest and Apoptosis in Mouse B Cells* , 1998, The Journal of Biological Chemistry.
[49] C. Deng,et al. Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[50] J. Massagué. TGF-beta signal transduction. , 1998, Annual review of biochemistry.
[51] J. Massagué,et al. Determinants of specificity in TGF-beta signal transduction. , 1998, Genes & development.
[52] P. Dijke,et al. DPC4 (SMAD4) mediates transforming growth factor-β1 (TGF-β1) induced growth inhibition and transcriptional response in breast tumour cells , 1997, Oncogene.
[53] K. Miyazono,et al. Alternatively Spliced Variant of Smad2 Lacking Exon 3 , 1999, The Journal of Biological Chemistry.
[54] T. Nakayama,et al. Smad6 functions as an intracellular antagonist of some TGF‐β family members during Xenopus embryogenesis , 1998, Genes to cells : devoted to molecular & cellular mechanisms.
[55] L. Nelles,et al. SIP1, a Novel Zinc Finger/Homeodomain Repressor, Interacts with Smad Proteins and Binds to 5′-CACCT Sequences in Candidate Target Genes* , 1999, The Journal of Biological Chemistry.
[56] M. Whitman. Signal transduction: Feedback from inhibitory SMADs , 1997, Nature.
[57] Xing Shen,et al. Smads bind directly to the Jun family of AP-1 transcription factors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[58] H. Vogel,et al. Smad5 is essential for left-right asymmetry in mice. , 2000, Developmental biology.
[59] A. Roberts,et al. A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction. , 2000, Genes & development.
[60] W. Vale,et al. Roles of pathway-specific and inhibitory Smads in activin receptor signaling. , 1999, Molecular endocrinology.
[61] P. Hoodless,et al. Specific Activation of Smad1 Signaling Pathways by the BMP7 Type I Receptor, ALK2* , 1998, The Journal of Biological Chemistry.
[62] Denis Vivien,et al. Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene , 1998, The EMBO journal.
[63] A. Atfi,et al. Induction of Apoptosis by DPC4, a Transcriptional Factor Regulated by Transforming Growth Factor-β through Stress-activated Protein Kinase/c-Jun N-terminal Kinase (SAPK/JNK) Signaling Pathway* , 1997, The Journal of Biological Chemistry.
[64] C. Heldin,et al. Identification and Functional Characterization of a Smad Binding Element (SBE) in the JunB Promoter That Acts as a Transforming Growth Factor-β, Activin, and Bone Morphogenetic Protein-inducible Enhancer* , 1998, The Journal of Biological Chemistry.
[65] K. Miyazono,et al. Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. , 1999, Science.
[66] T. Gelehrter,et al. Smad4/DPC4 and Smad3 Mediate Transforming Growth Factor-β (TGF-β) Signaling through Direct Binding to a Novel TGF-β-responsive Element in the Human Plasminogen Activator Inhibitor-1 Promoter* , 1998, The Journal of Biological Chemistry.
[67] R. Derynck,et al. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation. , 1998, Genes & development.
[68] K. Miyazono,et al. Interaction and Functional Cooperation of PEBP2/CBF with Smads , 1999, The Journal of Biological Chemistry.
[69] Irene L Andrulis,et al. MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal Carcinoma , 1996, Cell.
[70] R. Janknecht,et al. Activation of Smad1-mediated transcription by p300/CBP. , 1999, Biochimica et biophysica acta.
[71] E. Nishida,et al. Regulation of intracellular dynamics of Smad4 by its leucine‐rich nuclear export signal , 2000, EMBO reports.
[72] K. Miyazono,et al. E1A Inhibits Transforming Growth Factor-β Signaling through Binding to Smad Proteins* 210 , 1999, The Journal of Biological Chemistry.
[73] K. Luo,et al. Negative Feedback Regulation of TGF-β Signaling by the SnoN Oncoprotein , 1999 .
[74] Scott E. Kern,et al. DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.
[75] J. Massagué,et al. Ubiquitin-dependent degradation of TGF-β-activated Smad2 , 1999, Nature Cell Biology.
[76] R. Derynck,et al. Transcriptional Activators of TGF-β Responses: Smads , 1998, Cell.
[77] S. Tashiro,et al. ATF-2 Is a Common Nuclear Target of Smad and TAK1 Pathways in Transforming Growth Factor-β Signaling* , 1999, The Journal of Biological Chemistry.
[78] J. D. Brown,et al. CREB binding protein is a required coactivator for Smad-dependent, transforming growth factor beta transcriptional responses in endothelial cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[79] K. Kinzler,et al. Frequency of Smad gene mutations in human cancers. , 1997, Cancer research.
[80] R. Derynck,et al. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription , 1998, Nature.
[81] Minoru Watanabe,et al. Smad4 and FAST-1 in the assembly of activin-responsive factor , 1997, Nature.
[82] J. Massagué,et al. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. , 1998, Genes & development.
[83] T. Gelehrter,et al. Glucocorticoid receptor inhibits transforming growth factor-beta signaling by directly targeting the transcriptional activation function of Smad3. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[84] Yan Chen,et al. Regulation of Smad7 Promoter by Direct Association with Smad3 and Smad4* , 1999, The Journal of Biological Chemistry.
[85] M. Gimbrone,et al. A role for Smad6 in development and homeostasis of the cardiovascular system , 2000, Nature Genetics.
[86] C. Heldin,et al. Smad7 mediates apoptosis induced by transforming growth factor β in prostatic carcinoma cells , 2000, Current Biology.
[87] R. Davis,et al. Evidence for a Role of Rho-like GTPases and Stress-activated Protein Kinase/c-Jun N-terminal Kinase (SAPK/JNK) in Transforming Growth Factor β-mediated Signaling* , 1997, The Journal of Biological Chemistry.
[88] L. Khachigian,et al. Induction of Platelet-derived Growth Factor B-chain Expression by Transforming Growth Factor-β Involves Transactivation by Smads* , 2000, The Journal of Biological Chemistry.
[89] K. Miyazono,et al. Role of p300, a transcriptional coactivator, in signalling of TGF‐β , 1998, Genes to cells : devoted to molecular & cellular mechanisms.
[90] K. Isselbacher,et al. The MSG1 Non-DNA-binding Transactivator Binds to the p300/CBP Coactivators, Enhancing Their Functional Link to the Smad Transcription Factors* , 2000, The Journal of Biological Chemistry.
[91] J. Gauthier,et al. A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3 , 1999, Oncogene.
[92] J. Massagué,et al. The nuclear import function of Smad2 is masked by SARA and unmasked by TGFb-dependent phosphorylation , 2000, Nature Cell Biology.
[93] Hiroshi Shibuya,et al. BMP2-induced Apoptosis Is Mediated by Activation of the TAK1-p38 Kinase Pathway That Is Negatively Regulated by Smad6* , 2000, The Journal of Biological Chemistry.
[94] M. Mareel,et al. Evidence That Smad2 Is a Tumor Suppressor Implicated in the Control of Cellular Invasion* , 1999, The Journal of Biological Chemistry.
[95] M. Kretzschmar,et al. Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1 , 1997, Nature.
[96] Harold L. Moses,et al. Identification of STRAP, a Novel WD Domain Protein in Transforming Growth Factor-β Signaling* , 1998, The Journal of Biological Chemistry.
[97] J. Varga,et al. Interaction of Smad3 with a proximal smad‐binding element of the human α2(I) procollagen gene promoter required for transcriptional activation by TGF‐β , 2000 .
[98] C. Heldin,et al. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling , 1997, Nature.
[99] A. Moustakas,et al. Role of Smad Proteins and Transcription Factor Sp1 in p21Waf1/Cip1 Regulation by Transforming Growth Factor-β* , 2000, The Journal of Biological Chemistry.
[100] T. Shioda,et al. The Smad4 Activation Domain (SAD) Is a Proline-rich, p300-dependent Transcriptional Activation Domain* , 2000, The Journal of Biological Chemistry.
[101] Kirby D. Johnson,et al. Interaction of Smad Complexes with Tripartite DNA-binding Sites* , 1999, The Journal of Biological Chemistry.
[102] Jeffrey L. Wrana,et al. TβRI Phosphorylation of Smad2 on Ser465 and Ser467 Is Required for Smad2-Smad4 Complex Formation and Signaling* , 1997, The Journal of Biological Chemistry.
[103] J. Wrana,et al. The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling , 1997, Cell.
[104] Naoto Ueno,et al. Interaction between Wnt and TGF-β signalling pathways during formation of Spemann's organizer , 2000, Nature.
[105] Xu Cao,et al. Smad6 as a Transcriptional Corepressor* , 2000, The Journal of Biological Chemistry.
[106] K. Miyazono,et al. Characterization of a bone morphogenetic protein-responsive Smad-binding element. , 2000, Molecular biology of the cell.
[107] Kathleen R. Cho,et al. DPC4 gene in various tumor types. , 1996, Cancer research.
[108] M. Goumans,et al. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. , 2000, The International journal of developmental biology.
[109] J. Rossant,et al. The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. , 1998, Genes & development.
[110] L. Attisano,et al. Assignment of Transforming Growth Factor β1 and β3 and a Third New Ligand to the Type I Receptor ALK-1* , 1999, The Journal of Biological Chemistry.
[111] Yigong Shi,et al. The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF‐β receptors , 1998, The EMBO journal.
[112] Jeffrey L. Wrana,et al. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation , 1999, Nature.
[113] Xin-Hua Feng,et al. Microtubule Binding to Smads May Regulate TGFβ Activity , 2000 .
[114] P. Hoodless,et al. Smad2 Signaling in Extraembryonic Tissues Determines Anterior-Posterior Polarity of the Early Mouse Embryo , 1998, Cell.
[115] E. Nishida,et al. Identification of Two Smad4 Proteins in Xenopus , 1999, The Journal of Biological Chemistry.
[116] M. Bitzer,et al. Smad3 and Smad4 Mediate Transcriptional Activation of the Human Smad7 Promoter by Transforming Growth Factor β* , 2000, The Journal of Biological Chemistry.
[117] R. Derynck,et al. A kinase subdomain of transforming growth factor‐β (TGF‐β) type I receptor determines the TGF‐β intracellular signaling specificity , 1997 .
[118] K. Isselbacher,et al. Transcriptional activating activity of Smad4: roles of SMAD hetero-oligomerization and enhancement by an associating transactivator. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[119] K. Miyazono,et al. Characterization of type I receptors for transforming growth factor-beta and activin. , 1994, Science.
[120] K. Krieglstein,et al. Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis. , 2000, European journal of biochemistry.
[121] A. Roberts,et al. SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor beta. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[122] J. Massagué,et al. Structural basis of Smad2 recognition by the Smad anchor for receptor activation. , 2000, Science.
[123] Hiroyuki Miyoshi,et al. Intestinal Tumorigenesis in Compound Mutant Mice of both Dpc4(Smad4) and Apc Genes , 1998, Cell.
[124] C. Wernstedt,et al. Phosphorylation of Ser465 and Ser467 in the C Terminus of Smad2 Mediates Interaction with Smad4 and Is Required for Transforming Growth Factor-β Signaling* , 1997, The Journal of Biological Chemistry.
[125] X. F. Wang,et al. Targeted Disruption of Smad3 Reveals an Essential Role in Transforming Growth Factor β-Mediated Signal Transduction , 1999, Molecular and Cellular Biology.
[126] P. Howe,et al. TGF‐β induces fibronectin synthesis through a c‐Jun N‐terminal kinase‐dependent, Smad4‐independent pathway , 1999, The EMBO journal.
[127] H. Lodish,et al. Role of transforming growth factor beta in human disease. , 2000, The New England journal of medicine.
[128] J. Massagué,et al. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways , 1996, Nature.
[129] L. Baudhuin,et al. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1 , 2000, Nature Cell Biology.
[130] A. Roberts,et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF‐β , 1999, The EMBO journal.
[131] M. Matzuk,et al. Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. , 1999, Development.
[132] C. Heldin,et al. Physical and Functional Interaction of Murine andXenopus Smad7 with Bone Morphogenetic Protein Receptors and Transforming Growth Factor-β Receptors* , 1998, The Journal of Biological Chemistry.
[133] M. Yin,et al. Transforming Growth Factor β1 Enhances Platelet Aggregation through a Non-transcriptional Effect on the Fibrinogen Receptor* , 1999, The Journal of Biological Chemistry.
[134] A. Moustakas,et al. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[135] S. Germain,et al. Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif. , 2000, Genes & development.
[136] D. He,et al. Transforming growth factor beta -inducible independent binding of SMAD to the Smad7 promoter. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[137] K. Miyazono,et al. Smad6 Is a Smad1/5-induced Smad Inhibitor , 2000, The Journal of Biological Chemistry.
[138] L. Aaltonen,et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. , 1998, Science.
[139] P. Hoodless,et al. Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2. , 1998, Molecular cell.
[140] J. Massagué,et al. A Smad Transcriptional Corepressor , 1999, Cell.
[141] K. Yamato,et al. Differential Inhibition of Smad6 and Smad7 on Bone Morphogenetic Protein- and Activin-mediated Growth Arrest and Apoptosis in B Cells* , 1999, The Journal of Biological Chemistry.
[142] K. Miyazono,et al. Induction of Smad6 mRNA by bone morphogenetic proteins. , 1998, Biochemical and biophysical research communications.
[143] C. Heldin,et al. Efficient TGF-β Induction of the Smad7 Gene Requires Cooperation between AP-1, Sp1, and Smad Proteins on the Mouse Smad7 Promoter* , 2000, The Journal of Biological Chemistry.
[144] R. Kucherlapati,et al. Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[145] J. Massagué,et al. Smad4/DPC4 Silencing and Hyperactive Ras Jointly Disrupt Transforming Growth Factor-β Antiproliferative Responses in Colon Cancer Cells* , 1999, The Journal of Biological Chemistry.
[146] K. Miyazono,et al. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta. , 1994, The Journal of biological chemistry.
[147] J. Wrana,et al. Smads as transcriptional co-modulators. , 2000, Current opinion in cell biology.
[148] J. Massagué,et al. A human Mad protein acting as a BMP-regulated transcriptional activator , 1996, Nature.
[149] J. Massagué,et al. Transcriptional control by the TGF‐β/Smad signaling system , 2000 .
[150] Xiao-Fan Wang,et al. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein , 1997, Molecular and cellular biology.
[151] K. Miyazono,et al. c-Ski Acts as a Transcriptional Co-repressor in Transforming Growth Factor-β Signaling through Interaction with Smads* , 1999, The Journal of Biological Chemistry.
[152] E. Bottinger,et al. A mechanism of suppression of TGF–β/SMAD signaling by NF-κB/RelA , 2000, Genes & Development.
[153] J. Massagué,et al. Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway , 1999, Nature.
[154] L. Attisano,et al. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[155] R. Weinberg,et al. SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[156] J. Massagué,et al. A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras. , 1999, Genes & development.
[157] C. J. Gimeno,et al. Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[158] J. Massagué,et al. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4 , 1997, Nature.
[159] R. Derynck,et al. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors , 1994, The Journal of cell biology.
[160] J. Massagué,et al. Controlling TGF-β signaling , 2000, Genes & Development.
[161] X. Cao,et al. Smad1 Interacts with Homeobox DNA-binding Proteins in Bone Morphogenetic Protein Signaling* , 1999, The Journal of Biological Chemistry.
[162] T. Hunter,et al. TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300. , 1998, Genes & development.
[163] R. Derynck,et al. TGF- receptor signaling , 1997 .
[164] R. Derynck,et al. Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4 , 1997, Molecular and cellular biology.
[165] P. Donahoe,et al. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[166] Qiang Zhou,et al. The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. , 1999, Genes & development.
[167] C. Heldin,et al. Transforming Growth Factor β1 Induces Nuclear Export of Inhibitory Smad7* , 1998, The Journal of Biological Chemistry.
[168] Su‐Li Cheng,et al. Transforming Growth Factor-β Up-regulates the β5Integrin Subunit Expression via Sp1 and Smad Signaling* , 2000, The Journal of Biological Chemistry.
[169] K. Miyazono,et al. Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. , 1999, Science.
[170] C. Deng,et al. The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[171] C. Deng,et al. Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. , 1999, Development.